PamGene (Netherlands)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 31 papers

  • Research Article
  • Citations1

Abstract 1876: Distinct kinase signatures define therapeutically relevant subtypes in colorectal cancer

  • Apr 21, 2025
  • Cancer Research
  • Gitanjali Dharmadhikari +4
  • Open Access
  • PDF
  • Research Article
  • Citations6

Integrative Kinase Activity Profiling and Phosphoproteomics of rd10 Mouse Retina during cGMP-Dependent Retinal Degeneration.

  • Mar 19, 2024
  • International Journal of Molecular Sciences
  • Akanksha Roy +8
  • Open Access
  • Abstract

860P The IOpener study: Tyrosine kinase activity in peripheral lymphocytes to predict durable response to immune checkpoint inhibition in patients with advanced melanoma

  • Sep 01, 2022
  • Annals of Oncology
  • K De Joode +17
  • Open Access
  • Research Article
  • Citations99

TGF-β promotes microtube formation in glioblastoma through thrombospondin 1

  • Sep 20, 2021
  • Neuro-Oncology
  • Justin V Joseph +32
  • Open Access
  • PDF
  • Research Article
  • Citations53

Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation.

  • Sep 02, 2021
  • Cells
  • Jing Chen +5
  • Open Access
  • Abstract

OTME-14. TGF-beta signaling in microtube formation of glioblastoma

  • Jul 05, 2021
  • Neuro-oncology Advances
  • Simon Storevik +21
  • Open Access
  • Research Article
  • Citations14

Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean mice

  • Mar 27, 2021
  • Molecular Metabolism
  • Rachel M.b Bell +18
  • Open Access
  • PDF
  • Research Article
  • Citations24

The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity

  • May 04, 2020
  • The Journal of Endocrinology
  • Lisa L Koorneef +9
  • Research Article
  • Citations74

Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer.

  • Nov 15, 2019
  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • Suriyan Ponnusamy +14
  • Open Access
  • Preprint Article

Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis via SYK activation

  • Nov 13, 2019
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Tom Van Der Wel +13
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.